Aerobic Exercise for Concussion Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how certain markers in saliva can indicate recovery from a concussion during exercise. Researchers are testing whether specific proteins and molecules in saliva change as the brain heals and how varying exercise levels affect these changes. Participants will be divided into groups performing either high or low-volume aerobic exercise to assess the impact on recovery. The trial seeks adolescent and adult athletes diagnosed with a concussion within the last 10 days who can exercise safely. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on concussion recovery.
Will I have to stop taking my current medications?
The trial excludes participants who are currently taking medications for ADHD, learning disorders, depression, anxiety, or other medications that can affect heart rate. If you are on these medications, you would not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that aerobic exercise, whether in large or small amounts, is generally safe for people recovering from concussions. Studies have found that engaging in more than 150 minutes of aerobic exercise per week can improve sleep and reduce symptoms over time. Less exercise is also safe and can aid in symptom improvement.
For both high and low levels of exercise, starting soon after a concussion is safe as long as symptoms do not worsen. This exercise can help individuals return to normal activities more quickly.
In summary, both high and low amounts of aerobic exercise are well-tolerated by those recovering from concussions. Research supports that they generally help reduce symptoms and enhance recovery.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different levels of aerobic exercise might influence recovery from concussions, which is a fresh approach compared to traditional rest-focused recovery methods. By examining salivary biomarkers, the trial aims to gain insights into how exercise at varying intensities affects healing, potentially offering a more active recovery path. This could lead to personalized treatment plans that optimize recovery times and improve outcomes for those with concussions.
What evidence suggests that this trial's treatments could be effective for concussion recovery?
This trial will compare high-volume aerobic exercise with low-volume aerobic exercise for participants recovering from concussions. Research has shown that aerobic exercise aids concussion recovery. One study found that more exercise led to fewer symptoms after a month. Another study showed that exercise sped up recovery by about 4.64 days on average. Exercising for more than 160 minutes a week proved especially beneficial. Even less exercise helped reduce ongoing symptoms over time. Overall, whether in large or small amounts, aerobic exercise supports faster and better recovery from concussions.12367
Who Is on the Research Team?
John Leddy, MD
Principal Investigator
University at Buffalo
Barry Willer, PhD
Principal Investigator
University at Buffalo
Praveen Arany, DDS, PhD
Principal Investigator
University at Buffalo
Mohammad Nadir, MD, PhD
Principal Investigator
University at Buffalo
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including the Buffalo Concussion Physical Exam and saliva collection
Treatment
Participants receive individualized exercise prescriptions based on the Buffalo Concussion Treadmill Test results
Follow-up
Participants are monitored for recovery and changes in salivary biomarkers
What Are the Treatments Tested in This Trial?
Interventions
- High Volume Aerobic Exercise
- Low Volume Aerobic Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator